Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin.
نویسندگان
چکیده
Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin J Vikse, A Rygh, K Kaisen & R Omdal To cite this article: J Vikse, A Rygh, K Kaisen & R Omdal (2016): Life-threatening rituximabinduced pyoderma gangrenosum successfully treated with intravenous immunoglobulin, Scandinavian Journal of Rheumatology, DOI: 10.1080/03009742.2016.1241298 To link to this article: http://dx.doi.org/10.1080/03009742.2016.1241298
منابع مشابه
Intravenous Immunoglobulin as Salvage Therapy in Refractory Pyoderma Gangrenosum: Report of a Case and Review of the Literature
Pyoderma gangrenosum is a neutrophilic dermatosis that occurs both as a primary disorder as well as secondary to an underlying disease. Due to its low prevalence there are limited data on therapeutics, particularly in refractory cases. Here, we discuss a case successfully managed with intravenous immunoglobulin and review the supporting literature.
متن کاملPyoderma gangrenosum in a patient with chronic granulomatous disease
RATIONALE The simultaneous occurrence of pyoderma gangrenosum (PG) and chronic granulomatous disease (CGD) is uncommon and few cases have been reported worldwide. PATIENT CONCERNS PG is a rare, chronic, ulcerative, neutrophilic skin disease of unknown etiology that requires immunosuppressive treatment. CGD belongs to Primary Immune Deficiencies in which the main defect lies in an inability of...
متن کاملIntravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
Peristomal pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that is characterized by painful, necrotic ulcerations occurring in the area surrounding an abdominal stoma. PPG is typically seen in younger patients with active inflammatory bowel disease. The etiology and pathogenesis is largely unknown and risk factors are not well defined. Therapy typically involves a combinati...
متن کاملCase of Pyoderma Gangrenosum Associated with Ulcerative Colitis Successfully Treated with Infliximab
Pyoderma gangrenosum (PG) is a rare, ulcerating inflammatory skin disease. PG is often associated with systemic diseases, including inflammatory bowel disease (IBD). Herein, we report a case of PG associated with ulcerative colitis successfully treated with infliximab. Our case report supports the efficacy of infliximab for refractory case of PG with IBD.
متن کاملPyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone
PG: pyoderma gangrenosum TNF: tumor necrosis factor INTRODUCTION Pyoderma gangrenosum (PG) is a neutrophilic dermatosis with an important inflammatory component that usually presents as a nonhealing ulcer. This cutaneous disorder has been associated with several systemic conditions including inflammatory bowel disease. Treatment options for PG in pregnancy are limited. We present a case of pyod...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Scandinavian journal of rheumatology
دوره 46 5 شماره
صفحات -
تاریخ انتشار 2017